| Date Filed | Type | Description |
| 08/11/2023 |
4
| RUFFOLO ROBERT R (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Disposed/sold 683 options to buy
@ $6.6439, valued at
$4.5k
Disposed/sold 683 options to buy
@ $4.9984, valued at
$3.4k
Disposed/sold 3,754 options to buy
@ $7.51, valued at
$28.2k
|
|
| 06/07/2023 |
3
| RUFFOLO ROBERT R (Director) has filed a Form 3 on Elicio Therapeutics, Inc. |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| RUFFOLO ROBERT R (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 8,888 options to buy
@ $0.7632, valued at
$6.8k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| RUFFOLO ROBERT R (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Sold 6,750 shares
@ $10.36, valued at
$69.9k
Exercised 6,750 options to buy
@ $0.57, valued at
$3.8k
|
|
| 06/28/2021 |
4
| RUFFOLO ROBERT R (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 8,888 options to buy
@ $9.97, valued at
$88.6k
|
|
| 12/07/2020 |
4
| RUFFOLO ROBERT R (Director) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Granted 8,888 options to buy
@ $18, valued at
$160k
|
|
| 12/03/2020 |
3
| RUFFOLO ROBERT R (Director) has filed a Form 3 on Sigilon Therapeutics, Inc. |
| 08/29/2019 |
3/A
| RUFFOLO ROBERT R (Director) has filed a Form 3/A on Aridis Pharmaceuticals, Inc. |
| 08/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2018 |
3
| RUFFOLO ROBERT R (Director) has filed a Form 3 on Aridis Pharmaceuticals, Inc. |
| 06/18/2018 |
4
| RUFFOLO ROBERT R (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.54, valued at
$21.6k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |